首页> 外文期刊>Bioinformatics and Biology Insights >Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy
【24h】

Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy

机译:视网膜母细胞瘤发病机制中miRNA基因调控的计算和体外研究:miRNA模仿策略

获取原文
           

摘要

Purpose: Retinoblastoma (RB), a primary pediatric intraocular tumor, arises from primitive retinal layers. Several novel molecular strategies are being developed for the clinical management of RB. miRNAs are known to regulate cancer-relevant biological processes. Here, the role of selected miRNAs, namely, miR-532-5p and miR-486-3p, has been analyzed for potential therapeutic targeting in RB.Methods: A comprehensive bioinformatic analysis was performed to predict the posttranscriptional regulators (miRNAs) of the select panel of genes [Group 1: oncogenes (HMGA2, MYCN, SYK, FASN); Group 2: cancer stem cell markers (TACSTD, ABCG2, CD133, CD44, CD24) and Group 3: cell cycle regulatory proteins (p53, MDM2)] using Microcosm, DIANALAB, miRBase v 18, and REFSEQ database, and RNA hybrid. The expressions of five miRNAs, namely, miR-146b-5p, miR-532-5p, miR-142-5p, miR-328, and miR- 486-3p, were analyzed by qRT–PCR on primary RB tumor samples (n = 30; including 17 invasive RB tumors and 13 noninvasive RB tumors). Detailed complementary alignment between 5' seed sequence of differentially expressed miRNAs and the sequence of target genes was determined. Based on minimum energy level and piCTAR scores, the gene targets were selected. Functional roles of these miRNA clusters were studied by using mimics in cultured RB (Y79, Weri Rb-1) cells in vitro. The gene targets (SYK and FASN) of the studied miRNAs were confirmed by qRT-PCR and western blot analysis. Cell proliferation and apoptotic studies were performed.Results: Nearly 1948 miRNAs were identified in the in silico analysis, From this list, only 9 upregulated miRNAs (miR-146b-5p, miR-305, miR-663b, miR-299, miR-532-5p, miR-892b, miR-501, miR-142-5p, and miR-513b) and 10 downregulated miRNAs (miR-1254, miR-328, miR-133a, miR-1287, miR-1299, miR-375, miR-486-3p, miR-720, miR-98, and miR-122*) were found to be common with the RB serum miRNA profile. Downregulation of five miRNAs (miR-146b-5p, miR-532-5p, miR-142-5p, miR-328, and miR-486-3p) was confirmed experimentally. Predicted common oncogene targets (SYK and FASN) of miR-486-3p and miR-532-5p were evaluated for their mRNA and protein expression in these miRNA mimic-treated RB cells. Experimental overexpression of these miRNAs mediated apoptotic cell death without significantly altering the cell cycle in RB cells.Conclusion: Key miRNAs in RB pathogenesis were identified by an in silico approach. Downregulation of miR-486-3p and miR-532-5p in primary retinoblastoma tissues implicates their role in tumorigenesis. Prognostic and therapeutic potential of these miRNA was established by the miRNA mimic strategy.
机译:目的:视网膜母细胞瘤(RB)是一种原发性小儿眼内肿瘤,起源于原始视网膜层。正在开发几种新的分子策略用于RB的临床管理。已知miRNA可调节癌症相关的生物学过程。在这里,已经分析了选定的miRNA,即miR-532-5p和miR-486-3p在RB中的潜在治疗靶点的作用。方法:进行了全面的生物信息学分析,以预测miRNA的转录后调控因子选择基因组[组1:癌基因(HMGA2,MYCN,SYK,FASN);第2组:癌症干细胞标志物(TACSTD,ABCG2,CD133,CD44,CD24)和第3组:细胞周期调节蛋白(p53,MDM2)]使用Microcosm,DIANALAB,miRBase v 18和REFSEQ数据库以及RNA杂交。通过qRT-PCR对原发性RB肿瘤样品中的五个miRNA,即miR-146b-5p,miR-532-5p,miR-142-5p,miR-328和miR-486-3p的表达进行了分析(n = 30;包括17个浸润性RB肿瘤和13个非浸润性RB肿瘤)。确定了差异表达的miRNA的5'种子序列与靶基因序列之间的详细互补比对。根据最低能量水平和piCTAR分数,选择了基因靶标。通过在体外培养的RB(Y79,Weri Rb-1)细胞中使用模拟物研究了这些miRNA簇的功能作用。通过qRT-PCR和蛋白质印迹分析确定了所研究miRNA的基因靶标(SYK和FASN)。结果:在计算机分析中鉴定出近1948个miRNA,从该列表中仅发现9个上调的miRNA(miR-146b-5p,miR-305,miR-663b,miR-299,miR- 532-5p,miR-892b,miR-501,miR-142-5p和miR-513b)和10个下调的miRNA(miR-1254,miR-328,miR-133a,miR-1287,miR-1299,miR-发现375,miR-486-3p,miR-720,miR-98和miR-122 *与RB血清miRNA谱图常见。实验证实了五种miRNA(miR-146b-5p,miR-532-5p,miR-142-5p,miR-328和miR-486-3p)的下调。评估了miR-486-3p和miR-532-5p预测的常见癌基因靶标(SYK和FASN)在这些miRNA模拟物处理的RB细胞中的mRNA和蛋白质表达。这些miRNA的实验性过表达介导了凋亡细胞的死亡,而没有显着改变RB细胞的细胞周期。结论:通过计算机方法鉴定了RB发病机理中的关键miRNA。原发性视网膜母细胞瘤组织中miR-486-3p和miR-532-5p的下调暗示了它们在肿瘤发生中的作用。这些miRNA的预后和治疗潜力已通过miRNA模仿策略确立。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号